The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

Last updated: April 22, 2025
Sponsor: MCPHS University
Overall Status: Active - Recruiting

Phase

1

Condition

Myopic Macular Degeneration

Glaucoma

Macular Degeneration

Treatment

occupational therapy interventions for low vision care

Clinical Study ID

NCT06593405
IRB-2023-2024-84
  • Ages 50-100
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clients with AMD, DR or Glaucoma

  • Clients who choose to participate will allow their deidentified data to be evaluatedfor outcomes.

Exclusion

Exclusion Criteria:

  • Clients with other age related eye diseases other than AMD, DR or Glaucoma.

  • Clients who do not wish to participate in this study.

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: occupational therapy interventions for low vision care
Phase: 1
Study Start date:
April 22, 2025
Estimated Completion Date:
December 05, 2026

Study Description

Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

Connect with a study center

  • MCPHS 10 Lincoln Square

    Worcester, Massachusetts 01608
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.